Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ethamsylate (500mg) Tablet
Therapeutic Category
Cardiovascular, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Strip
Packaging
10*10
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Etastyle 500 Tablet contains Ethamsylate (500mg), a hemostatic agent that works to prevent excessive bleeding and promotes clotting by stabilizing capillary blood vessels. It enhances platelet aggregation, improving blood coagulation in individuals experiencing bleeding due to various conditions such as menorrhagia (heavy menstrual bleeding), epistaxis (nosebleeds), or post-operative hemorrhage.
Ethamsylate's action is primarily focused on strengthening the capillary walls, thus reducing the fragility of blood vessels, and preventing leakage of blood into surrounding tissues. It also promotes the stabilization of platelet membranes, which helps in faster clot formation. This makes Etastyle 500 Tablet beneficial in both medical and surgical settings, providing support in conditions that require hemostatic therapy.
The tablet is widely used in gynecological treatments to control heavy menstrual bleeding and to manage bleeding episodes in patients undergoing surgery or those with bleeding disorders. Its use can also extend to individuals suffering from gastrointestinal bleeding or hemorrhagic disorders.
Common side effects may include nausea, headache, dizziness, and rash. Rarely, allergic reactions or gastrointestinal discomfort may occur.
Etastyle 500 Tablet is indicated for the treatment and prevention of excessive bleeding in conditions such as menorrhagia, epistaxis, and during or after surgeries.
Consult your healthcare provider before use, especially if pregnant, breastfeeding, or taking anticoagulants.
Store in a cool, dry place, away from direct sunlight and moisture.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ethamsylate 500mg Tablet is a higher-strength hemostatic medicine used to control excessive bleeding, making it a strong hospital and specialty prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in heavy menstrual bleeding, gynecological disorders, surgical bleeding control, dental procedures, trauma cases, and post-operative care. It is commonly used in hospitals, gynecology clinics, and emergency departments.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Ethamsylate 500mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital demand, gynecology and surgical usage, and repeat institutional orders when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hemostatic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.